Countable Labs Sets a New Standard in Molecular Testing for Hematologic Malignancy Clinical Applications

Countable Labs announced the Ancora assay line for molecular testing of hematologic malignancies, marking its entry into clinical markets. The launch expands the company into clinical diagnostics, but the release provides no financial projections, regulatory milestones, commercial revenue, or performance data.